Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Neogen reports robust Q2 earnings, targets $1B revenue by 2025

Neogen's Q2 2023 earnings call highlighted impressive revenue growth, improved margins, and strategic focus on integration and customer service.
While facing challenges related to increased debt levels and operational complexities, Neogen aims for ambitious revenue and EBITDA targets by 2025.
The company's performance underscores its potential for continued success in the Food Safety and Animal Safety segments through organic growth and financial discipline.

Neogen reports robust Q3 earnings, focuses on data analytics growth

Neogen's Q3 performance reflects strong revenue growth and strategic focus on data analytics for food security. While challenges exist in certain business segments, the company remains optimistic about long-term opportunities and integration synergies.

Neogen reports stellar Q4 results, eyes growth through integration

Neogen's Q4 2023 earnings call highlighted robust financial performance, successful integration of acquired divisions, and strategic outlook for fiscal '24. The company's focus on growth, innovation, and market expansion positions it well for continued success in the food safety and animal health sectors.

Neogen reports robust Q1 earnings, eyes growth amid regional challenges

Neogen's Q1 2024 showed strong revenue growth but faced challenges in core revenue.
The company highlighted progress in key segments like Food Safety and genomics.
Efficiency issues from ERP implementation impacted revenue timing.
Management remains optimistic about the full-year outlook despite regional challenges.

Neogen reports flat Q2 revenues, focuses on integration and market challenges

Neogen's Q2 performance was mixed, with strengths in certain segments and challenges in others. The company remains optimistic about its long-term prospects despite market headwinds.

Neogen reports improved margins in Q3 despite integration challenges

Neogen's Q3 2024 performance showed improvements in gross margin and EBITDA, but challenges with shipping inefficiencies and integration impacted revenue growth. The company is focused on resolving operational inefficiencies and regaining lost customers to achieve long-term growth goals.

Neogen reports Q4 revenue growth but faces EBITDA margin decline

Neogen's Q4 showed mixed performance with revenue growth but declining EBITDA margins.
The company faces challenges in the soft food safety end market and supply constraints.
However, Neogen is focusing on innovation and underpenetrated markets for future growth.

Neogen reports Q1 revenue decline, focuses on food safety growth

Neogen's Q1 performance showed mixed results with revenue decline and EBITDA pressure.
The company's strengths lie in its strategic positioning in food safety and customer-focused approach.
Challenges persist in certain segments, requiring operational adjustments for sustained growth.
Identified opportunities in geographic expansion and strategic investments can drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Neogen's (NEOG) proprietary testing platform gets upgraded to reduce the incidence of bacterial contamination in livestock.

Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?

Why Is Neogen (NEOG) Up 4.4% Since Last Earnings Report?

President & CEO of Neogen Corp (30-Year Financial, Insider Trades) John Edward Adent (insider trades) sold 31,489 shares of NEOG on 08/05/2019 at an average price of $69.03 a share.

Neogen Corp (NEOG) President & CEO John Edward Adent Sold $2.2 million of Shares

Neogen Corp (NASDAQ:NEOG) files its latest 10-K with SEC for the fiscal year ended on May 31, 2019.

Neogen Corp (NEOG) Files 10-K for the Fiscal Year Ended on May 31, 2019

VP & CFO of Neogen Corp (30-Year Financial, Insider Trades) Steven J. Quinlan (insider trades) sold 15,000 shares of NEOG on 07/25/2019 at an average price of $69.04 a share.

Neogen Corp (NEOG) VP & CFO Steven J. Quinlan Sold $1 million of Shares

Neogen's (NEOG) strong international business and solid performance by core Food Safety segment resulted in year-over-year revenue growth.

Neogen's (NEOG) Q4 Earnings Beat Estimates, Revenues Miss

Neogen Corporation (NEOG) CEO John Adent on Q4 2019 Results - Earnings Call Transcript

Neogen (NEOG) delivered earnings and revenue surprises of 7.14% and -1.09%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Tops Q4 Earnings Estimates

Investors' trust continues to be high in Neogen (NEO), thanks to strength in its Food Safety and Genomic businesses.

Here's Why You Should Hold Onto Neogen (NEOG) Stock Now

Why Is Neogen (NEOG) Up 4.2% Since Last Earnings Report?

Neogen exits fiscal third quarter on a disappointing note due to poor performance of Animal Safety segment.

Neogen Hurt by Weakness in Animal Safety, Currency Woes

Continued weakness in the global animal protein market and strongly negative currency conversions posed as headwinds for Neogen (NEOG) in third-quarter fiscal 2019.

Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3

Neogen Corporation (NEOG) CEO John Adent on Q3 2019 Results - Earnings Call Transcript

News for Neogen Stock (NEOG)